Hippo Holdings (NYSE: HIPO) director awarded RSUs and stock via Form 4

Rhea-AI Filing Summary

Holliday Susan Claire reported acquisition or exercise transactions in this Form 4 filing.

Hippo Holdings Inc. director Susan Claire Holliday reported two equity compensation transactions in the form of common stock and restricted stock units (RSUs). She received an award of 4,808 RSUs, each convertible into one share of common stock upon vesting, and now directly holds 7,310 shares including these RSUs. A separate block of 2,502 RSUs granted on October 1, 2025 vested and settled into 2,502 shares of common stock at a stated value of $25.40 per share, which she now holds directly. These are compensation-related grants and vesting events, not open-market purchases or sales.

Insights

Equity compensation analyst

Director received routine stock-based compensation via RSU vesting and a new grant.

Susan Claire Holliday, a director of Hippo Holdings Inc., reported two compensation-related acquisitions of common stock. One reflects vesting of 2,502 previously granted RSUs, delivering shares at a stated value of $25.40 per share. The other is a new award of 4,808 RSUs that will convert into common stock upon future vesting.

These transactions are coded as awards (transaction code A), not open-market buys or sells, so they mainly show how the company pays its directors. Following the transactions, she directly holds 7,310 shares, including 4,808 RSUs, indicating a modest equity stake with ongoing alignment to shareholders.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Holliday Susan Claire

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,502	$25.40	$64K
Grant/Award	Common Stock	4,808	$0.00	--

Holdings After Transaction: Common Stock — 2,502 shares (Direct, null)

Footnotes (1)

1. Vesting/settlement of 2,502 RSUs originally granted on Oct 1, 2025 into Common Stock Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting that occurs following the date of grant, subject to the Reporting Person continuing in service to the Issuer and its subsidiaries through such vesting date. Includes 4,808 RSUs.

Key Figures

RSUs vested: 2,502 shares Vested RSU share value: $25.40 per share New RSU award: 4,808 RSUs +1 more

4 metrics

RSUs vested 2,502 shares RSUs originally granted on October 1, 2025 vesting into common stock

Vested RSU share value $25.40 per share Stated value for 2,502 vested RSUs settled into common stock

New RSU award 4,808 RSUs Award of RSUs, each convertible into one share upon vesting

Total direct holdings after transactions 7,310 shares Includes 4,808 RSUs as noted in the footnotes

Key Terms

restricted stock units ("RSUs"), vesting/settlement, Annual Meeting

3 terms

restricted stock units ("RSUs") financial

"Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vesting/settlement financial

"Vesting/settlement of 2,502 RSUs originally granted on Oct 1, 2025 into Common Stock"

Annual Meeting financial

"The RSUs will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting that occurs following the date of grant"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holliday Susan Claire

(Last) (First) (Middle)

1 S ALMADEN BLVD., SUITE 400

(Street)

SAN JOSE CALIFORNIA 95113

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hippo Holdings Inc. [ HIPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		A		2,502(1)	A	$25.4	2,502	D
Common Stock	06/02/2026		A		4,808(2)	A	$0.00	7,310(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Vesting/settlement of 2,502 RSUs originally granted on Oct 1, 2025 into Common Stock

2. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the Annual Meeting that occurs following the date of grant, subject to the Reporting Person continuing in service to the Issuer and its subsidiaries through such vesting date.

3. Includes 4,808 RSUs.

Remarks:

	/s /Guy Zeltser, Attorney-in-Fact for Susan Claire Holliday	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Hippo Holdings (HIPO) director Susan Claire Holliday report on this Form 4?

She reported two equity compensation transactions, both categorized as grants or awards, not market trades. One is the vesting of 2,502 RSUs into common stock, and the other is a new award of 4,808 RSUs that will vest in the future.

How many Hippo Holdings (HIPO) shares did Susan Claire Holliday acquire in total?

She acquired 2,502 shares of common stock through RSU vesting and an additional 4,808 RSUs that convert into one share each upon vesting. After these transactions, she directly holds 7,310 shares, which includes the 4,808 RSUs described in the filing footnotes.

What is the vesting schedule of Susan Claire Holliday’s new 4,808 RSUs at Hippo Holdings (HIPO)?

The 4,808 RSUs will vest in full on the earlier of the first anniversary of the grant date or immediately before the next Annual Meeting after the grant. Vesting requires her continued service with Hippo Holdings Inc. or its subsidiaries through the applicable vesting date.

What is the significance of the 2,502 RSUs that vested for Hippo Holdings (HIPO) director Holliday?

These 2,502 RSUs were originally granted on October 1, 2025 and have now vested and settled into 2,502 shares of common stock at a stated value of $25.40 per share. This reflects previously awarded compensation becoming fully earned and delivered as stock.

Are Susan Claire Holliday’s Hippo Holdings (HIPO) Form 4 transactions open-market purchases or sales?

No. Both transactions are coded with transaction code A, indicating grants or awards. One represents vesting of previously granted RSUs into common stock, and the other is a new RSU award. There are no open-market purchases or sales reported in this Form 4.